Oncology & Cancer

Discovery paves way for improved ovarian cancer care

Australian scientists have revealed a better way to identify which patients should respond to powerful ovarian cancer drugs called PARP inhibitors (PARPi), resolving an important question in ovarian cancer care about why ...

Oncology & Cancer

UVA developing 'two-headed arrow' to kill ovarian cancer

A University of Virginia School of Medicine researcher is developing a two-fisted, antibody-based approach to destroy deadly ovarian cancer—an approach he believes could also be modified to kill breast, prostate and other ...

Oncology & Cancer

Targeting gene mutations to treat ovarian cancers

New research has shown that ovarian cancer patients with a tumour mutation in the BRAF gene respond exceptionally well to treatment with targeted drugs, known as BRAF inhibitors.

Oncology & Cancer

Stopping the spread of ovarian cancer

Molecules that are important for a developing fetus have also been shown to drive the spread of ovarian cancer in adult women, according to Sydney researchers.

page 39 from 40